Jasmin Quandt
University of Chicago(US)BioNTech (Germany)(DE)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Cancer Immunotherapy and Biomarkers, COVID-19 Clinical Research Studies, Immune Cell Function and Interaction
Most-Cited Works
- → COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses(2020)2,020 cited
- → BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans(2021)818 cited
- → A vaccine targeting mutant IDH1 induces antitumour immunity(2014)690 cited
- → Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes(2022)218 cited
- → BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans(2020)171 cited
- → Wnt–β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression(2021)86 cited
- → Concurrent human antibody and T H 1 type T-cell responses elicited by a COVID-19 RNA vaccine(2020)67 cited
- → TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4+CD8+ thymocytes(2018)64 cited
- → Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses(2018)41 cited
- → Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses(2021)33 cited